Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38


The roles of apo(a) size, phenotype, and dominance pattern in PCSK9-inhibition-induced reduction in Lp(a) with alirocumab.

Enkhmaa B, Anuurad E, Zhang W, Yue K, Li CS, Berglund L.

J Lipid Res. 2017 Oct;58(10):2008-2016. doi: 10.1194/jlr.M078212. Epub 2017 Aug 10.


Lipoprotein(a) and HIV: Allele-Specific Apolipoprotein(a) Levels Predict Carotid Intima-Media Thickness in HIV-Infected Young Women in the Women's Interagency HIV Study.

Enkhmaa B, Anuurad E, Zhang W, Li CS, Kaplan R, Lazar J, Merenstein D, Karim R, Aouizerat B, Cohen M, Butler K, Pahwa S, Ofotokun I, Adimora AA, Golub E, Berglund L.

Arterioscler Thromb Vasc Biol. 2017 May;37(5):997-1004. doi: 10.1161/ATVBAHA.117.309137. Epub 2017 Mar 23.


LPA Gene, Ethnicity, and Cardiovascular Events.

Lee SR, Prasad A, Choi YS, Xing C, Clopton P, Witztum JL, Tsimikas S.

Circulation. 2017 Jan 17;135(3):251-263. doi: 10.1161/CIRCULATIONAHA.116.024611. Epub 2016 Nov 9.


Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Nordestgaard BG, Langsted A.

J Lipid Res. 2016 Nov;57(11):1953-1975. Epub 2016 Sep 27. Review.


Structure, function, and genetics of lipoprotein (a).

Schmidt K, Noureen A, Kronenberg F, Utermann G.

J Lipid Res. 2016 Aug;57(8):1339-59. doi: 10.1194/jlr.R067314. Epub 2016 Apr 13. Review.


Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome.

Enkhmaa B, Anuurad E, Zhang W, Abbuthalha A, Kaur P, Visla J, Karakas S, Berglund L.

Clin Endocrinol (Oxf). 2015 Sep 4. doi: 10.1111/cen.12937. [Epub ahead of print]


Attenuated age-impact on systemic inflammatory markers in the presence of a metabolic burden.

Erdembileg A, Mirsoian A, Enkhmaa B, Zhang W, Beckett LA, Murphy WJ, Berglund LF.

PLoS One. 2015 Mar 27;10(3):e0121947. doi: 10.1371/journal.pone.0121947. eCollection 2015. Erratum in: PLoS One. 2015;10(4):e0127137.


Rhesus monkey (Macaca mulatta) lipoprotein(a) and apolipoprotein(a): high frequency of small size apolipoprotein(a) isoforms.

Enkhmaa B, Abbuthalha A, Anuurad E, Zhang W, Tarantal AF, Berglund L.

J Med Primatol. 2015 Jun;44(3):117-24. doi: 10.1111/jmp.12160. Epub 2015 Feb 12.


Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans.

Enkhmaa B, Anuurad E, Zhang W, Berglund L.

Atherosclerosis. 2014 Jul;235(1):223-9. doi: 10.1016/j.atherosclerosis.2014.04.035. Epub 2014 May 10.


LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography.

Santos PC, Bueno CT, Lemos PA, Krieger JE, Pereira AC.

Lipids Health Dis. 2014 Apr 29;13:74. doi: 10.1186/1476-511X-13-74.


The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?

Ye Z, Haycock PC, Gurdasani D, Pomilla C, Boekholdt SM, Tsimikas S, Khaw KT, Wareham NJ, Sandhu MS, Forouhi NG.

Diabetes. 2014 Jan;63(1):332-342. doi: 10.2337/db13-1144. Epub 2013 Oct 2.


Association study of lipoprotein(a) genetic markers, traditional risk factors, and coronary heart disease in HIV-1-infected patients.

Egaña-Gorroño L, Martínez E, Escribà T, Calvo M, Gatell JM, Arnedo M.

Front Immunol. 2012 Dec 6;3:367. doi: 10.3389/fimmu.2012.00367. eCollection 2012.


HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels.

Enkhmaa B, Anuurad E, Zhang W, Abbuthalha A, Li XD, Dotterweich W, Pollard RB, Asmuth DM, Berglund L.

Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):387-92. doi: 10.1161/ATVBAHA.112.300125. Epub 2012 Nov 29.


Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study.

Virani SS, Brautbar A, Davis BC, Nambi V, Hoogeveen RC, Sharrett AR, Coresh J, Mosley TH, Morrisett JD, Catellier DJ, Folsom AR, Boerwinkle E, Ballantyne CM.

Circulation. 2012 Jan 17;125(2):241-9. doi: 10.1161/CIRCULATIONAHA.111.045120. Epub 2011 Nov 29.


Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians.

Enkhmaa B, Anuurad E, Ozturk Z, Zhang W, Pearson TA, Berglund L.

Transl Res. 2011 Aug;158(2):92-8. doi: 10.1016/j.trsl.2011.01.004. Epub 2011 Feb 5.


Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk.

Enkhmaa B, Anuurad E, Zhang W, Tran T, Berglund L.

Metab Syndr Relat Disord. 2011 Dec;9(6):411-8. doi: 10.1089/met.2011.0026. Epub 2011 Jul 12. Review.


Age as a modulator of inflammatory cardiovascular risk factors.

Anuurad E, Enkhmaa B, Gungor Z, Zhang W, Tracy RP, Pearson TA, Kim K, Berglund L.

Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2151-6. doi: 10.1161/ATVBAHA.111.232348. Epub 2011 Jun 23.


Enigmatic role of lipoprotein(a) in cardiovascular disease.

Anuurad E, Enkhmaa B, Berglund L.

Clin Transl Sci. 2010 Dec;3(6):327-32. doi: 10.1111/j.1752-8062.2010.00238.x.


Integrated role of two apoliprotein E polymorphisms on apolipoprotein B levels and coronary artery disease in a biethnic population.

Ozturk Z, Enkhmaa B, Shachter NS, Berglund L, Anuurad E.

Metab Syndr Relat Disord. 2010 Dec;8(6):531-8. doi: 10.1089/met.2010.0034. Epub 2010 Aug 17.

Supplemental Content

Support Center